Abstract
Purpose. The gadopentetic acid (Gd-DTPA)-loaded chitosan nanoparticles (Gd-nanoCPs) were prepared for gadolinium neutron-capture therapy (Gd-NCT) and characterized and evaluated as a device for intratumoral (i.t.) injection.
Methods. Gd-nanoCPs were prepared by a novel emulsion-droplet coalescence technique. The effects of the deacetylation degree of chitosan and Gd-DTPA concentration in chitosan medium on the particle size and the gadolinium content in Gd-nanoCPs were examined. In vitro Gd-DTPA release from Gd-nanoCPs was evaluated using an isotonic phosphate-buffered saline solution (PBS, pH 7.4) and human plasma. In vivo Gd-DTPA retention in the tumor after i.t. injection of Gd-nanoCPs was estimated on mice bearing s.c. B16F10 melanoma.
Results. Gd-nanoCPs with the highest Gd content, which were obtained using 100% deacetylated chitosan in 15% Gd-DTPA aqueous solution, were 452 nm in diameter and 45% in Gd-DTPA content. A lower deacetylation degree of chitosan led to an increase in particle size and a decrease in Gd-DTPA content in Gd-nanoCPs. As Gd-DTPA concentration in the chitosan solution increased, Gd-DTPA content in Gd-nanoCPs increased but the particle size did not vary. Gd-DTPA loaded to Gd-nanoCPs was hardly released over 7 days in PBS (1.8%) despite the high water solubility of Gd-DTPA. In contrast, 91% of Gd-DTPA was released in plasma over 24 hours. When Gd-nanoCPs were i.t. injected, 92% of Gd-DTPA injected effectually without outflow was held in the tumor tissue for 24 hours, which was different from the case of gadopentetate solution injection (only 1.2%).
Conclusions. Gd-nanoCPs highly incorporating Gd-DTPA were successfully prepared by the emulsion-droplet coalescence technique. Their releasing properties and their ability for long-term retention of Gd-DTPA in the tumor indicated that Gd-nanoCPs might be useful as an i.t. injectable device for Gd-NCT.
Similar content being viewed by others
REFERENCES
Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur. J. Pharm. Biopharm. 45:41-48 (1998).
J. Vandorpe, E. Schacht, S. Dunn, A. Hawley, S. Stolnik, S.S. Davis, M. C. Garnett, M. C. Davies, and L. Illum. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. Biomaterials 18:1147-1152 (1997).
J.-C. Leroux, E. Allémann, F. De Jaeghere, E. Doelker, and R. Gurny. Biodegradable nanoparticles—From sustained release formulations to improved site specific drug delivery. J. Contr. Rel. 39:339-350 (1996).
B. G. Müller, H. Leuenberger, and T. Kissel. Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm. Res. 13:32-37 (1996).
T. Verrecchia, G. Spenlehauer, D. V. Bazile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Contr. Rel. 36:49-61 (1995).
G. Skjask-Braek, T. Anthonsen, and P. Sandford. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier Applied Science, London, 1989.
O. Felt, P. Buri, and R. Gurny. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:979-993 (1998).
R. M. Brugger and J. A. Shih. Evaluation of gadolinium-157 as a neutron capture therapy agent. Strahlenther. Onkol. 165:153-156 (1989).
R. F. Barth and A. H. Soloway. Boron neutron capture therapy of primary and metastatic brain tumors. Mol. Chem. Neuropathol. 21:139-154 (1994).
Y. Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura, and T. Nakagawa. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-malanoma cell interaction from in vitro to first clinical trial. Pigment Cell Res. 2:226-234 (1989).
R. C. Greenwood, C. W. Reich, H. A. Baader, H. R. Koch, D. Breitig, O. W. B. Schult, B. Fogelberg, A. Bäcklin, W. Mampe, T. von Egidy, and K. Schreckenbach. Collective and two-quasiparticle states in 158Gd observed through study of radiative neutron capture in 157Gd. Nucl. Phys. A304:327-428 (1978).
R. F. Martin, G. D'cunha, M. Pardee, and B. J. Allen. Induction of doublestrand breaks following neutron capture by DNA-bound 157Gd. Int. J. Radiat. Biol. 54:205-208 (1988).
V. F. Khokhlov, P. N. Yashkin, D. I. Silin, E. S. Djorova, and R. Lawaczeck. Neutron capture therapy with Gd-DTPA in tumor-bearing rats. In Y. Mishima (ed), Cancer Neutron Capture Therapy, Plenum Press, New York, 1996, pp. 865-869.
R. Lawaczeck, C.-O. Fischer, U. Krüger, W. Leuther, and J. Menrad. Gadolinium neutron capture therapy (GdNCT) with MRI contrast media. In vitro study. In Y. Mishima (ed), Cancer Neutron Capture Therapy, Plenum Press, New York, 1996, pp. 859-864.
Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, H. Churei, C. L. Pechoux, T. Kobayashi, and K. Kanda. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy. Jpn. J. Cancer Res. 84:841-843 (1993).
M. Takagaki, Y. Oda, S. Miyatake, H. Kikuchi, T. Kobayashi, K. Kanda, and Y. Ujeno. Killing effects of gadolinium neutron capture reactions on brain tumors. In B. J. Allen et al. (eds.), Progress in Neutron Capture Therapy for Cancer, Plenum Press, New York, 1992, pp. 407-410.
Y. Fukumori, H. Ichikawa, H. Tokumitsu, M. Miyamoto, K. Jono, R. Kanamori, Y. Akine, and N. Tokita. Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process. Chem. Pharm. Bull. 41:1144-1148 (1993).
Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, Y. Fukumori, H. Tokumitsu, R. Kanamori, T. Kobayashi, and K. Kanda. Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules. J. Cancer Res. Clin. Oncol. 119:71-73 (1992).
H. Tokumitsu, H. Ichikawa, Y. Fukumori, and L. H. Block. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem. Pharm. Bull. 47:838-842 (1999).
A. Matsumura, Y. Shibata, T. Yamamoto, K. Nakagawa, S. Yasuda, S. Nakajima, I. Sakata, T. Yoshizawa, and T. Nose. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging. Neurol. Med. Chir. (Tokyo) 37:327-331 (1997).
Y. M. Wang, H. Sato, I. Adachi, and I. Horikoshi. Optimization of the formulation design of chitosan microspheres containing cisplatin. J. Pharm. Sci. 85:1204-1210 (1996).
S. R. Jameela, A. Misra, and A. Jayakrishnan. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J. Biomater. Sci. Polymer Edn. 6:621-632 (1994).
A. Polk, B. Amsden, K. De Yao, T. Peng, and M. F. A. Goosen. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:178-185 (1994).
A. Berthold, K. Cremer, and J. Kreuter. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Contr. Rel. 39:17-25 (1996).
P. Calvo, C. Remuñan-López, J. L. Vila-Jato, and M. J. Alonso. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14:1431-1436 (1997)
L. Y. Lim and L. S. C. Wan. Heat treatment of chitosan films. Drug Dev. Ind. Pharm. 21:839-846 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tokumitsu, H., Ichikawa, H. & Fukumori, Y. Chitosan-Gadopentetic Acid Complex Nanoparticles for Gadolinium Neutron-Capture Therapy of Cancer: Preparation by Novel Emulsion-Droplet Coalescence Technique and Characterization. Pharm Res 16, 1830–1835 (1999). https://doi.org/10.1023/A:1018995124527
Issue Date:
DOI: https://doi.org/10.1023/A:1018995124527